On chromosome 1q21.3, apart from well-established AD-associated FLG mutations and psoriasis-associated deletion of LCE3B-LCE3C, FLG-AS1 is a plausible candidate to mediate differential AD/psoriasis risk via the network of regulatory elements coordinating gene expression.57 This evidence concerns the gene LCE3C and psoriasis.